Their study showed that DCIS patients with pathogenic variants in BRCA1/2 and PALB2 had a higher risk of developing invasive breast cancer than those without.

Risk factors for the development of invasive cancer in unresected ductal carcinoma in situ. Eur J Surg Oncol. 2018 Apr;44(4):429-435.

Discover the debate surrounding the labeling of DCIS as a cancer diagnosis and its impact on patient treatment and research ...

It is most often found during a mammogram. Invasive ductal carcinoma (IDC), also known as infiltrating ductal carcinoma or invasive breast cancer, starts in the milk ducts of the breast and ...

First, Dr Burstein highlights findings from the COMET study, which examined recurrence rates in patients with ductal carcinoma in situ ... a noninferior rate of invasive cancer vs those undergoing ...